Bee venom exhibits anti-cancer effects on tongue carcinoma cells by arresting cell cycle, inducing apoptosis, and

Enas Sabry1, Hagar M Zayed1, Ola M Ezzatt1,2

  • 1Ain Shams University, Faculty of Dentistry, Department of Oral Medicine, Periodontology and Oral Diagnosis, Cairo, Egypt.

Abstract

Insights

Honey bee venom (BV) exhibits anti-cancer effects against tongue squamous cell carcinoma (TSCC) by inducing apoptosis and reducing cell migration. Further research is needed to explore BV as a potential therapy for tongue carcinoma.

Area of Science:

  • Oncology
  • Biochemistry

Background:

  • Tongue squamous cell carcinoma (TSCC) is an aggressive cancer known for treatment resistance.
  • Honey bee venom (BV) contains bioactive compounds with potential therapeutic properties.

Purpose of the Study:

  • To investigate the in vitro anti-cancer effects of honey bee venom (BV) on a human tongue squamous cell carcinoma (TSCC) cell line.
  • To determine BV's impact on TSCC cell viability, proliferation, apoptosis, and migration.

Main Methods:

  • Cytotoxicity assays were performed to determine the IC50 of BV on HNO-97 cells.
  • Apoptosis was assessed via Annexin V assay and BAX/BCL-2 gene expression analysis.
  • Cell cycle analysis and Transwell migration assays evaluated BV's effects on proliferation and migration.

Main Results:

  • BV demonstrated dose-dependent cytotoxicity with an IC50 of 12.96 μg/mL against HNO-97 cells.
  • BV induced cell cycle arrest, reduced cell migration, and modulated BAX and BCL-2 gene expression.
  • Significant decrease in BCL-2 (p=0.001) and increase in BAX (p=0.03) gene expression were observed.

Conclusions:

  • Honey bee venom exhibits significant anti-cancer activity against human TSCC in vitro.
  • BV induces apoptosis and inhibits cell migration in TSCC cells.
  • These findings support further preclinical studies of BV as a potential alternative therapy for tongue carcinoma.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K